Clinical Trial Update: Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of irinotecan plus cyclosporine for metastatic, advanced, or locally recurrent colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University of Chicago | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED